US Stock MarketDetailed Quotes

TScan Therapeutics (TCRX)

Watchlist
  • 1.050
  • -0.080-7.08%
Close Mar 13 16:00 ET
  • 1.070
  • +0.020+1.90%
Post 19:38 ET
59.75MMarket Cap-1.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TScan Therapeutics (TCRX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
Development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of2.51M100.00%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.82M100.00%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +1.24%
Sample Name
Sample Code
 +1.20%
Sample Name
Sample Code
 +1.06%
4
Tempus AI
TEM
+0.91%
5
Roblox
RBLX
+0.21%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.59%
Sample Name
Sample Code
 +15.30%
Sample Name
Sample Code
 +12.93%
4
ZTO Express
ZTO
+5.44%
5
GDS Holdings
GDS
+4.87%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -